JMIR Cancer Receives New Journal Impact Factor
(Toronto, ON, June 19, 2025) JMIR Publications is pleased to announce that JMIR Cancer has received a Journal Impact Factor of 2.7, as published in Journal Citation Reports 2025 from Clarivate.
Published Date:
JMIR Cancer Accepted for MEDLINE Indexing
We are pleased to announce that JMIR Cancer has been accepted for inclusion in MEDLINE, which is the U.S. National Library of Medicine's premier bibliographic database.
Published Date:
JMIR Cancer Receives a Journal Impact Factor of 3.3
JMIR Publications is pleased to announce that JMIR Cancer has received a Journal Impact Factor (JIF) of 3.3 as published in the 2024 Journal Citation Report (JCR) from Clarivate.
...
Published Date:
JMIR Cancer Receives Inaugural Impact Factor of 2.8
JMIR Publications is pleased to announce that JMIR Cancer, indexed in
Published Date:
JMIR Cancer Expected to Receive Impact Factor in 2023
The JMIR Cancer has been indexed by Clarivate since 2015 and will receive its' first Impact Factor in 2023
...
Published Date:
JMIR Cancer Receives Prestigious DOAJ Seal
JMIR Publications is happy to announce that JMIR Cancer has been awarded the prestigious Directory of Open Access Journals (DOAJ) Seal. The DOAJ Seal is awarded to journals that demonstrate best practice in open access publishing. Only 10% of the 15,000 peer-reviewed journals indexed in DOAJ have been awarded this Seal.
...
Published Date:
JMIR Cancer Now Indexed in Scopus
(Toronto, May 12, 2020) We are happy to announce that JMIR Cancer, which published its first article in 2015, has been accepted for inclusion in Elsevier’s Scopus.
JMIR Publications is pleased to have the following journals indexed/accepted in Scopus:
- Journal of Medical Internet Research
- JMIR mHealth & uHealth
- JMIR Research Protocols
- JMIR Human Factors
- JMIR Mental Health
- JMIR Serious Games
Published Date:
JMIR Cancer accepted for PMC and PubMed
Update Apr 17, 2017: This process is finalized, JMIR Cancer can now be found in PubMed and in PubMed Central.
(Toronto, Jan 31st, 2017) We are pleased to announce that JMIR Cancer (JC) has been accepted by the scientific evaluators at NCBI for indexing in PubMed Central and&nbs...
Published Date:
JMIR Cancer seeking Editorial Board and Editor-in-Chief nominations
We are currently seeking academic leaders in this field to apply as section editors for Editorial Board positions for JMIR Cancer including the Editor-in-Chief. There will be remuneration in form of a credit system, rewarding actions such as taking on papers as submission editor. EB members will also be able to use a small discount for their own papers, or papers they invite from other authors.
Prequisites include a...
Published Date:
How JMIR is maximizing dissemination and impact of your research
JMIR Publications is proud to partner with TrendMD, offering JMIR authors additional visibility for their articles, displaying their articles across the TrendMD publisher network, which includes publishers such as BMJ or the JAMA network.
In addition to "organic" displays, JMIR authors can also pay for additional dissemination packages on TrendMD or Twitter ($99 each), which drives traffic and citations. See JMIR Research Dissemination Partnership with TrendMD (
Published Date: